Topics

Tmunity and UC San Francisco Announce Exclusive License and Research Collaboration to Advance TCR T Cell Therapies for Pediatric Cancers

07:00 EDT 1 May 2019 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
– Collaboration will broaden Tmunity’s pipeline to include a glioma T cell therapy engineered to express a newly discovered T cell receptor – – Initial research will focus on Diffuse Intrinsic Pontine Glioma, a ...

Other Sources for this Article

Investor:
Graeme Bell
ir@tmunity.com
(215) 966-1600

Tmunity Media:
Mike Beyer, Sam Brown Inc.
mikebeyer@sambrown.com
(312) 961-2502

UCSF Media:
Laura Kurtzman
Senior Public Information Officer
(415) 476-3163
Laura.kurtzman@ucsf.edu

NEXT ARTICLE

More From BioPortfolio on "Tmunity and UC San Francisco Announce Exclusive License and Research Collaboration to Advance TCR T Cell Therapies for Pediatric Cancers"

Quick Search

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Pediatrics
Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...